2873 Stock Overview
Guiyang Xintian Pharmaceutical Co.,Ltd. se dedica a la investigación y desarrollo, producción y venta de nuevos medicamentos chinos patentados para diversas enfermedades en China.
Snowflake Score | |
---|---|
Valuation | 1/6 |
Future Growth | 5/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 2/6 |
Guiyang Xintian Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥12.52 |
52 Week High | CN¥15.24 |
52 Week Low | CN¥7.59 |
Beta | -0.12 |
1 Month Change | 18.67% |
3 Month Change | 3.47% |
1 Year Change | -12.32% |
3 Year Change | 54.53% |
5 Year Change | 31.58% |
Change since IPO | 57.36% |
Recent News & Updates
Shareholder Returns
2873 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | -2.9% | 0.7% | 0.9% |
1Y | -12.3% | -14.7% | -16.5% |
Rentabilidad frente al sector: 002873 superó al sector CN Pharmaceuticals , que obtuvo un rendimiento del -13% el año pasado.
Rentabilidad vs. Mercado: 002873 superó al mercado CN, que obtuvo un rendimiento del -12.6% el año pasado.
Price Volatility
2873 volatility | |
---|---|
2873 Average Weekly Movement | 9.7% |
Pharmaceuticals Industry Average Movement | 7.2% |
Market Average Movement | 8.3% |
10% most volatile stocks in CN Market | 11.6% |
10% least volatile stocks in CN Market | 5.2% |
Precio estable de las acciones: 002873ha sido volátil en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de 002873 (3%) se ha mantenido estable durante el año pasado.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1995 | 923 | Da Lun Dong | https://www.gyxtyy.com |
Guiyang Xintian Pharmaceutical Co.,Ltd. se dedica a la investigación y desarrollo, producción y venta de nuevos medicamentos chinos patentados para diversas enfermedades en China. La empresa ofrece productos de formulación, que incluyen cápsulas duras, gránulos, comprimidos, mezclas, jarabes, licores, rocíos, polvos, suspensiones y geles.
Guiyang Xintian Pharmaceutical Co.,Ltd. Fundamentals Summary
2873 fundamental statistics | |
---|---|
Market cap | CN¥2.88b |
Earnings (TTM) | CN¥98.93m |
Revenue (TTM) | CN¥994.10m |
29.1x
P/E Ratio2.9x
P/S RatioIs 2873 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
2873 income statement (TTM) | |
---|---|
Revenue | CN¥994.10m |
Cost of Revenue | CN¥231.05m |
Gross Profit | CN¥763.05m |
Other Expenses | CN¥664.13m |
Earnings | CN¥98.93m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 12, 2024
Earnings per share (EPS) | 0.43 |
Gross Margin | 76.76% |
Net Profit Margin | 9.95% |
Debt/Equity Ratio | 55.6% |
How did 2873 perform over the long term?
See historical performance and comparison